ATC Group: A02BA03 Famotidine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A02BA03 in the ATC hierarchy

Level	Code	Title
`1`	A	Alimentary tract and metabolism
`2`	A02	Drugs for acid related disorders
`3`	A02B	DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
`4`	A02BA	H2-receptor antagonists
`5`	A02BA03	Famotidine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	40 mg
PAREN	Parenteral	40 mg

Active ingredients in A02BA03

Active Ingredient
Famotidine
Famotidine is a potent competitive H₂-receptor antagonist. Famotidine has a rapid onset of action and, at the recommended doses, has a long duration of action and is highly effective at relatively low blood concentrations.

Related product monographs

Document	Type	Information Source
FAMOPSIN 20mg Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
FAMOPSIN 40mg Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
PEPCID AC Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)
PEPCID Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)
PEPCID Oral suspension	MPI, US: SPL/PLR	FDA, National Drug Code (US)
ULCEDINE Film coated table	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
ULCERAN Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)